Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Opinion & Analysis (TSXV:TLT)

Buzz on the Bullboards: Stockhouse favorites still top the list

Stockhouse Editorial October 24, 2017

Using laser technology to cure cancer

Stockhouse Editorial September 8, 2017

Buzz on the Bullboards: Big Three still dominating discussions

Stockhouse Editorial August 28, 2017

Buzz on the Bullboards: Biotech back in the spotlight (T.PLI)

Stockhouse Editorial August 14, 2017

Buzz on the Bullboards: Theralase Technologies

Stockhouse Editorial July 25, 2017

VIDEO: Using Lasers to Heal Pain and Treat Cancer

BTV-Business Television June 28, 2016

VIDEO: Theralase Technologies is Destroying Cancer Cells

BTV-Business Television June 28, 2016

Takeover battle possible for Silvercrest Mines Corp. (T.FR)

Stockhouse Editorial July 27, 2015

Theralase (V.TLT) achieves almost perfect kill rate of cancer cells, Stockhouse poster says

Stockhouse Editorial July 23, 2015

The cheapest medical device stock this Stockhouse poster has ever seen

Stockhouse Editorial July 2, 2015

Yamana Gold (T.YRI) worth more sold than run another day by CEO

Stockhouse Editorial May 4, 2015

Potash marketing agency Canpotex finalizes 2015 supply contracts

Stockhouse Editorial March 30, 2015

Silicon Valley venture capital firm invests in weed space (C.MMJ)

Stockhouse Editorial January 8, 2015

Sintana Energy (V.SNN) looks cheap with Exxon (XOM) drilling

Stockhouse Editorial January 6, 2015

Will C.IMH turn out to be a marijuana revenue story?

Stockhouse Editorial December 23, 2014

Our 2wk 75% gain on TLT + 2015 risks & hot spots

Danny Deadlock December 19, 2014

It’s time to start speculating about Petromanas (V.PMI) takeout price?

Stockhouse Editorial December 17, 2014

37-cent V.TLT, a fascinating cancer speculation

Danny Deadlock December 5, 2014

VIDEO: Theralase Technologies More Than 1 Million Patients Treated

BTV-Business Television June 25, 2014